Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ICPT | INTERCEPT PHARMACEUTICALS, INC. | ROSA-BJORKESON DAGMAR | Director | Nov 08, 2023 | Option Exercise | $19.00 | 26,391 | 501,429 | 0 | Nov 13, 2023, 02:43 PM | |
MNK | Mallinckrodt plc | ROSA-BJORKESON DAGMAR | Chief Strat & Corp Dev Officer | Jun 01, 2019 | Option Exercise | $9.06 | 246 | 2,229 | 23,431 | Jun 04, 2019, 04:08 PM | |
MNK | Mallinckrodt plc | ROSA-BJORKESON DAGMAR | Chief Strat & Corp Dev Officer | Apr 02, 2019 | Option Exercise | $22.80 | 1,063 | 24,236 | 22,428 | Apr 03, 2019, 06:13 PM | |
MNK | Mallinckrodt plc | ROSA-BJORKESON DAGMAR | Chief Strat & Corp Dev Officer | Jun 01, 2018 | Option Exercise | $17.05 | 247 | 4,211 | 15,853 | Jun 05, 2018, 04:14 PM | |
BXLT | Baxalta Inc | ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | Mar 03, 2016 | Option Exercise | $39.30 | 982 | 38,593 | 71,137 | Mar 07, 2016, 06:20 PM | |
BXLT | Baxalta Inc | ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | Dec 01, 2015 | Option Exercise | $34.63 | 6,893 | 238,705 | 56,737 | Dec 07, 2015, 07:49 PM | |
BXLT | Baxalta Inc | ROSA-BJORKESON DAGMAR | EVP and President, Biosimilars | Dec 01, 2015 | Option Exercise | $34.63 | 6,893 | 238,705 | 11,610 | Dec 03, 2015, 06:18 PM |